Clinical Trial

A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Intravenous glucocorticoid (IVGC) is an accessible and effective therapy for Graves orbitopathy (GO); the 4.5-g weekly protocol is well studied, but many details of treatment protocols need to be clarified. The goal of this trial is to compare the efficacy and safety of weekly and daily protocol of IVGC in GO. Researchers will compare daily protocol to weekly protocol to see if daily protocol works to treat GO.
Trial Details
NCT Number NCT06510114
Lead Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Conditions Graves Ophthalmopathy
Enrollment 150 participants
Start Date 2024-07
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-19